GMP-Ready Genesynthesis Manufacturing

GMP-Ready Genesynthesis Manufacturing
Product Description

DNA Productsnagene provides fully sequence-verified DNA products manufactured under GMP-compliant processes. Our portfolio includes circular plasmid DNA, linearized plasmid DNA and gene fragments for gene therapy, cell therapy, mRNA and synthetic biology applications.
Products are manufactured in Vienna, Austria under ISO 9001-certified quality systems with full batch traceability and release documentation. All plasmid products undergo NGS-based identity verification and can be supplied with additional quality control parameters, including endotoxin testing.

Nagene Gmbh

  • Country/Region:
    Austria
  • Founded:
    2023
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Start-up
Specifications
  • Details
    Circular plasmid DNA up to 20 kb Linearized plasmid DNA up to 20 kb 
    Gene fragments up to 1.5 kb 
    Full sequence verification by NGS 
    GMP-compliant manufacturing processes 
    Gene therapy 
    Cell therapy 
    mRNA production 
    AAV vector development 
    Synthetic biology
  • Selling Points
    Circular plasmid DNA, linearized plasmid DNA and gene fragments from a single supplier
    Manufactured in Vienna, Austria
    GMP-compliant processes according to EudraLex Vol. 4 Part II
    NGS-based identity verification
    Optional endotoxin and bioburden testing
    Full batch traceability
    CoA, CoC, TSE/BSE and AOF statements availableSupport for advanced therapy development programs
  • Model
    Custom Service
  • Supplied from
    Austria

Nagene Gmbh

  • Country/Region:
    Austria
  • Founded:
    2023
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Start-up

Nagene Gmbh resources (1)

  • Brochure GMP-Compliant Gene Synthesis

    nagene provides GMP-compliant gene synthesis solutions for regulated and advanced therapeutic applications. Our portfolio includes custom plasmid DNA, gene fragments and glycerol stocks, supported by full traceability, NGS-based sequence verification and comprehensive batch documentation.

    Designed for complex gene constructs and demanding development programs, our platform supports gene therapy, mRNA, AAV and other advanced therapy applications. With production in approximately five days and scalable manufacturing from microgram to milligram quantities, nagene delivers reliable DNA products for research and regulated environments.